Targeting NUR77 for mitigating perinatal neuroinflammation
US10869851B1 · kind B1 · utility
0Cited by
0References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 9, 2018 |
| Grant date | Dec 22, 2020 |
| Priority date | — |
| Expiry date | Mar 9, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compositions and methods of inhibiting Nur77 in a subject for treatment of perinatal neuroinflammation, preterm labor, or preterm birth are provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.